Compare ARK Genomic Revolution ETF (ARKG) vs Invesco S&P 500 High Div Low Volatility ETF (SPHD) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Invesco S&P 500 High Div Low Volatility ETF — how do they compare? ARK Genomic Revolution ETF trades at $40.95, while Invesco S&P 500 High Div Low Volatility ETF trades at $51.9. Which is the better fit depends on your goals.
| ARKG | SPHD | |
|---|---|---|
Sector | Sector/Thematic | — |
52-Week High | $43.57 | $52.63 |
52-Week Low | $23.09 | $46.96 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
SPHD trades at $51.82, up 0.76% with a bullish technical outlook supported by moving averages and strong trend momentum indicators. The ETF focuses on high-dividend, low-volatility S&P 500 stocks, offering a 4.5% SEC yield with monthly distributions. Recent news highlights its defensive positioning and reliability for income investors, though historical returns have lagged the broader market.
SPHD presents a conservative income opportunity with defensive sector exposure, but faces underperformance risk versus growth-oriented ETFs. The bullish technical setup and consistent dividend payments support near-term stability, though long-term total return potential may be limited compared to the S&P 500.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Invesco S&P 500 High Div Low Volatility ETF
The fund generally will invest at least 90% of its total assets in the securities that comprise the underlying index. Strictly in accordance with its guidelines and mandated procedures, S&P Dow Jones Indices LLC (the “index Provider”) compiles, maintains and calculates the underlying index, which is designed to measure the performance of 50 least volatile high yielding constituents of the S&P 500 ® Index in the past year.
Read more on SPHD →
